Published Year: 2021
Global Next Generation Ultrasound Systems Market: Focus on Product Type, Technology, and Application
The global next-generation ultrasound systems market was valued at $8,246.8 million in 2020...
Market Research Report
A quick peek into the report
Table of Contents
Product Definition
2.1 Scope of Study
2.2 Inclusion and Exclusion Criteria
2.2.1 Inclusion Criteria
2.2.2 Exclusion Criteria
2.3 Key Questions Answered in the Report
3.1 Primary Data Sources
3.2 Secondary Data Sources
3.3 Data Sources Categorization
3.4 Selection Criteria for Company Profiles
3.5 Brief Overview of the Market Estimation Process
3.6 Data Validation
3.7 Assumptions and Limitations
4.1 Impact of COVID-19 on Prevalence of Urological Disorders
4.2 Impact of COVID-19 on Adoption of Urology Care Devices and Platforms
4.3 Impact on Market Size of Global Urology Care Devices and Platforms Market
4.3.1 Scenario Comparative Analysis
4.4 Impact of COVID-19 on Global Urology Care Devices and Platforms Market
4.4.1 Short-Term Impact (2-4 Years)
4.4.2 Mid-Term Impact (5-10 Years)
4.4.3 Long-Term Impact (8-12 Years)
4.5 Future Outlook and Recommendations
5.1 Disease Epidemiology
5.1.1 Kidney Diseases
5.1.2 Urological Cancer
5.1.3 Other Urological Diseases
5.2 Procedure Volume Analysis
5.2.1 Transurethral Prostatectomy
5.2.2 Open Prostatectomy
5.2.3 Laparoscopic Hysterectomy
5.2.4 Hysterectomy
6.1 Key Trends
6.1.1 Short-Term Potential (2-4 Years)
6.1.2 Long-Term Potential (8-12 Years)
6.2 Value Chain Analysis
6.3 End-User Perceptions
6.4 Regulatory Framework
6.4.1 Regulatory Framework in North America
6.4.1.1 U.S. Food and Drug Administration
6.4.1.2 Health Canada
6.4.2 Regulatory Framework in Europe
6.4.3 Regulatory Framework in Asia-Pacific
6.4.3.1 National Medical Products Administration (NMPA)
6.4.3.2 Pharmaceutical and Medical Device Agency (PMDA)
6.5 Patent Landscape
6.5.1 Awaited Technological Developments
6.5.2 Patent Filing Trend
6.6 Product Benchmarking
6.7 Ongoing Clinical Trials
7.1 Market Share Analysis
7.1.1 Market Share Analysis for Conventional Urology Devices
7.1.2 Market Share Analysis for Advanced Devices
7.1.3 Market Share Analysis for Platforms
7.2 Key Strategies and Development
7.2.1 Regulatory and Legal Activities
7.2.2 Partnerships and Alliances
7.2.3 New Offerings
7.2.4 Mergers and Acquisitions
7.2.5 Expansion Activities
7.2.6 Funding Activities
7.3 Business Model Analysis
7.4 Pipeline Analysis
8.1 Assumptions and Limitations
8.2 Key Findings and Opportunity Assessment
8.2.1 Key Findings:
8.2.2 Opportunity Assessment:
8.3 Global Urology Care Devices and Platforms Market Size and Forecast
8.3.1 Realistic Growth Scenario
8.3.2 Pessimistic/Conservative Growth Scenario
8.3.3 Optimistic Growth Scenario
8.4 Market Dynamics
8.4.1 Impact Analysis
8.4.2 Market Growth Promoting Factors
8.4.2.1 Rising Prevalence of Urological Disorders
8.4.2.2 Rising Technology Integration in Urology Care
8.4.2.3 Product Portfolio Expansion Through Mergers and Acquisitions
8.4.3 Market Growth Restraining Factors
8.4.3.1 High Upfront Cost of Devices
8.4.3.2 Data Privacy Concerns
8.4.4 Market Growth Opportunities
8.4.4.1 Adoption of Telesurgery in Urology Care
8.4.4.2 Emergence of Regional Companies in Global Urology Care Devices and Platforms Market
8.4.4.3 Development of Remote Patient Monitoring Devices
9.1 Opportunity Assessment
9.2 Devices
9.2.1 Conventional Devices
9.2.1.1 Instruments
9.2.1.1.1 Dialysis Devices
9.2.1.1.1.1 Hemodialysis Devices
9.2.1.1.1.2 Peritoneal Dialysis Devices
9.2.1.1.2 Endoscopy and Imaging Devices
9.2.1.1.2.1 Ureteroscopes
9.2.1.1.2.2 Nephroscopes
9.2.1.1.2.3 Cystoscopes
9.2.1.1.2.4 Others
9.2.1.1.3 Lasers and Lithotripsy Devices
9.2.1.1.4 Endoscopy Fluid Management System
9.2.1.1.5 Insufflators
9.2.1.1.6 Urodynamic Systems
9.2.1.2 Consumables and Accessories
9.2.1.2.1 Guidewires and Catheters
9.2.1.2.2 Ureteral Stents
9.2.1.2.3 Biopsy Devices
9.2.1.2.4 Others
9.2.2 Advanced Devices
9.2.2.1 Neurostimulator
9.2.2.2 Robotic System
9.2.2.3 Others
9.3 Platforms
10.1 Opportunity Assessment
10.2 Treatment
10.3 Diagnostics and Monitoring
11.1 Opportunity Assessment
11.2 Hospitals, Ambulatory Surgery Centers, and Clinics
11.3 Dialysis Centers
11.4 Homecare Settings
12.1 Opportunity Assessment
12.2 Kidney Diseases
12.3 Urological Cancer and Benign Prostatic Hyperplasia (BPH)
12.4 Pelvic Organ Prolapse
12.5 Other Diseases
13.1 Overview
13.2 North America Global Urology Care Devices and Platforms Market
13.2.1 Key Findings
13.2.2 Market Dynamics: Impact Analysis
13.2.3 Market Size and Forecast
13.2.4 North America Urology Care Devices and Platforms Market (by Indication)
13.2.5 North America Urology Care Devices and Platforms Market (by End User)
13.2.6 North America Urology Care Devices and Platforms Market (by Country)
13.2.6.1 U.S.
13.2.6.1.1 Key Findings
13.2.6.1.2 Market Size and Forecast
13.2.6.2 Canada
13.2.6.2.1 Key Findings
13.2.6.2.2 Market Size and Forecast
13.3 Europe Urology Care Devices and Platforms Market
13.3.1 Key Findings
13.3.2 Market Dynamics: Impact Analysis
13.3.3 Market Size and Forecast
13.3.4 Europe Urology Care Devices and Platforms Market (by Indication)
13.3.5 Europe Urology Care Devices and Platforms Market (by End User)
13.3.6 Europe Urology Care Devices and Platforms Market (by Country)
13.3.6.1 Germany
13.3.6.1.1 Key Findings
13.3.6.1.2 Market Size and Forecast
13.3.6.2 U.K.
13.3.6.2.1 Key Findings
13.3.6.2.2 Market Size and Forecast
13.3.6.3 France
13.3.6.3.1 Key Findings
13.3.6.3.2 Market Size and Forecast
13.3.6.4 Italy
13.3.6.4.1 Key Findings
13.3.6.4.2 Market Size and Forecast
13.3.6.5 Spain
13.3.6.5.1 Key Findings
13.3.6.5.2 Market Size and Forecast
13.3.6.6 Rest-of-Europe
13.3.6.6.1 Key Findings
13.3.6.6.2 Market Size and Forecast
13.4 Asia-Pacific Urology Care Devices and Platforms Market
13.4.1 Key Findings
13.4.2 Market Dynamics: Impact Analysis
13.4.3 Market Size and Forecast
13.4.4 Asia-Pacific Urology Care Devices and Platforms Market (by Indication)
13.4.5 Asia-Pacific Urology Care Devices and Platforms Market (by End User)
13.4.6 Asia-Pacific Urology Care Devices and Platforms Market (by Country)
13.4.6.1 Japan
13.4.6.1.1 Key Findings
13.4.6.1.2 Market Size and Forecast
13.4.6.2 China
13.4.6.2.1 Key Findings
13.4.6.2.2 Market Size and Forecast
13.4.6.3 India
13.4.6.3.1 Key Findings
13.4.6.3.2 Market Size and Forecast
13.4.6.4 South Korea
13.4.6.4.1 Key Findings
13.4.6.4.2 Market Size and Forecast
13.4.6.5 Australia and New Zealand
13.4.6.5.1 Key Findings
13.4.6.5.2 Market Size and Forecast
13.4.6.6 Rest-of-Asia-Pacific
13.4.6.6.1 Key Findings
13.4.6.6.2 Market Size and Forecast
13.5 Latin America Urology Care and Devices Market
13.5.1 Key Findings
13.5.2 Market Dynamics: Impact Analysis
13.5.3 Market Size and Forecast
13.5.4 Latin America Urology Care Devices and Platforms Market (by Indication)
13.5.5 Latin America Urology Care Devices and Platforms Market (by End User)
13.5.6 Latin America Urology Care Devices and Platforms Market (by Country)
13.5.6.1 Brazil
13.5.6.1.1 Key Findings
13.5.6.1.2 Market Size and Forecast
13.5.6.2 Mexico
13.5.6.2.1 Key Findings
13.5.6.2.2 Market Size and Forecast
13.5.6.3 Argentina
13.5.6.3.1 Key Findings
13.5.6.3.2 Market Size and Forecast
13.5.6.4 Rest-of-Latin-America
13.5.6.4.1 Key Findings
13.5.6.4.2 Market Size and Forecast
13.6 Middle East and Africa Urology Care Devices and Platforms Market
13.6.1 Key Findings
13.6.2 Market Dynamics: Impact Analysis
13.6.3 Market Size and Forecast
13.6.4 Middle East and Africa Urology Care Devices and Platforms Market (by Indication)
13.6.5 Middle East and Africa Urology Care Devices and Platforms Market (by End User)
13.6.6 Middle East and Africa Urology Care Devices and Platforms Market (by Country)
13.6.6.1 K.S.A.
13.6.6.1.1 Key Findings
13.6.6.1.2 Market Size and Forecast
13.6.6.2 Israel
13.6.6.2.1 Key Findings
13.6.6.2.2 Market Size and Forecast
13.6.6.3 South Africa
13.6.6.3.1 Key Findings
13.6.6.3.2 Market Size and Forecast
13.6.6.4 Rest-of-Middle East and Africa (Rest-of-MEA)
13.6.6.4.1 Key Findings
13.6.6.4.2 Market Size and Forecast
14.1 Avenda Health
14.1.1 Company Overview
14.1.2 Role of Avenda Health in the Global Urology Care Devices and Platforms Market
14.1.3 Recent Developments
14.1.4 SWOT Analysis
14.2 B. Braun Melsungen AG
14.2.1 Company Overview
14.2.2 Role of B. Braun Melsungen AG in the Global Urology Care Devices and Platforms Market
14.2.3 Financials
14.2.4 Recent Developments
14.2.5 SWOT Analysis
14.3 Becton, Dickinson and Company
14.3.1 Company Overview
14.3.2 Role of Becton, Dickinson and Company in Global Urology Care Devices and Platforms Market
14.3.3 Financials
14.3.4 Recent Developments
14.3.5 SWOT Analysis
14.4 Boston Scientific Corporation
14.4.1 Company Overview
14.4.2 Role of Boston Scientific Corporation in the Global Urology Care Devices and Platforms Market
14.4.3 Financials
14.4.4 Recent Developments
14.4.5 SWOT Analysis
14.5 Cardinal Health, Inc.
14.5.1 Company Overview
14.5.2 Role of Cardinal Health, Inc. in Global Urology Devices and Platforms Market
14.5.3 Financials
14.5.4 Recent Developments
14.5.5 SWOT Analysis
14.6 Cook Group
14.6.1 Company Overview
14.6.2 Role of Cook Group in the Global Urology Care Devices and Platforms Market
14.6.3 SWOT Analysis
14.7 Fresenius Medical Care AG & Co. KGaA
14.7.1 Company Overview
14.7.2 Role of Fresenius Medical Care AG & Co. KGaA in Urology Care Devices and Platforms Market
14.7.3 Financials
14.7.4 Recent Developments
14.7.5 SWOT Analysis
14.8 Intuitive Surgical, Inc.
14.8.1 Company Overview
14.8.2 Role of Intuitive Surgical, Inc. in the Global Urology Care Devices and Platforms Market
14.8.3 Financials
14.8.4 SWOT Analysis
14.9 KARL STORZ SE & Co KG
14.9.1 Company Overview
14.9.2 Role of KARL STORZ SE & Co. KG in the Global Urology Care Devices and Platforms Market
14.9.3 SWOT Analysis
14.10 Lucida Medical Ltd
14.10.1 Company Overview
14.10.2 Role of Lucida Medical Ltd in the Global Urology Care Devices and Platforms Market
14.10.3 Recent Developments
14.10.4 SWOT Analysis
14.11 Medtronic plc
14.11.1 Company Overview
14.11.2 Role of Medtronic plc in the Global Urology Care Devices and Platforms Market
14.11.3 Financials
14.11.4 Recent Developments
14.11.5 SWOT Analysis
14.12 Px HealthCare Ltd.
14.12.1 Company Overview
14.12.2 Role of Px Healthcare Ltd. in the Global Urology Care Devices and Platforms Market
14.12.3 Recent Developments
14.12.4 SWOT Analysis
14.13 Richard Wolf GmbH
14.13.1 Company Overview
14.13.2 Role of Richard Wolf GmbH in the Global Urology Care Devices and Platforms Market
14.13.3 Recent Developments
14.13.4 SWOT Analysis
14.14 Rocamed
14.14.1 Company Overview
14.14.2 Role of Rocamed in the Global Urology Care Devices and Platforms Market
14.14.3 SWOT Analysis
14.15 Urologix, LLC.
14.15.1 Company Overview
14.15.2 Role of Urologix, LLC. in the Global Urology Care Devices and Platforms Market
14.15.3 SWOT Analysis
14.16 Company Snapshots
14.16.1 Axonics Modulation Technologies, Inc.
14.16.1.1 Company Overview
14.16.1.2 Role of Axonics Modulation Technologies, Inc. in Global Urology Care Devices and Platforms Market
14.16.1.3 Recent Development
14.16.2 Valencia Technologies Corporation
14.16.2.1 Company Overview
14.16.2.2 Role of Valencia Technologies in the Global Urology Care and Platforms Market
14.16.2.3 Recent Developments
14.16.3 NanoVibronix, Inc.
14.16.3.1 Company Overview
14.16.3.2 Role of NanoVibronix, Inc. in Global Urology Care Devices and Platforms Market
14.16.3.3 Recent Developments
14.16.4 I-O Urology
14.16.4.1 Company Overview
14.16.4.2 Role of I-O Urology in Global Urology Care Devices and Platforms Market
14.16.4.3 Recent Developments
14.16.5 CareLogiQ Corp.
14.16.5.1 Company Overview
14.16.5.2 Role of CareLogiQ Corp. in the Global Urology Care Devices and Platforms Market
14.16.5.3 Recent Developments
14.16.6 Renalytix AI plc
14.16.6.1 Company Overview
14.16.6.2 Role of Renalytix AI plc in Global Urology Care Devices and Platforms Markets
14.16.6.3 Recent Developments
Table 1: Global Urology Care Devices and Platforms Market, Quarterly Regional Impact, 2020
Table 2: Global Urology Care Devices and Platforms Market, Key Technology Trends
Table 3.1: Secondary Data Sources
Table 6.1: Global Urology Care Devices and Platforms Market: Awaited Technologies
Table 6.2: Global Urology Care Devices and Platforms Market: Product Benchmarking Analysis (by Product Type)
Table 6.3: Global Urology Care Devices and Platforms Market: Product Benchmarking Analysis (by Device Type)
Table 6.4: Global Urology Care Devices and Platforms Market: Ongoing Clinical Trials
Table 7.1: Global Urology Care Devices and Platforms Market, Business Model Analysis
Table 7.2: Global Urology Care Devices and Platforms Market, Product Pipeline
Table 13.1: Prevalence of Chronic Kidney Disease and Diabetes in North America, 2018 and 2019
Table 13.2: North America Urology Care Devices and Platforms Market, Impact Analysis
Table 13.3: Prevalence of Chronic Kidney Disease and Diabetes in Europe, 2018 and 2019
Table 13.4: Europe Urology Care Devices and Platforms Market, Impact Analysis
Table 13.5: Prevalence of Chronic Kidney Disease and Diabetes in Asia-Pacific, 2018 and 2019
Table 13.6: Asia-Pacific Urology Care Devices and Platforms Market, Impact Analysis
Table 13.7: Prevalence of Chronic Kidney Disease and Diabetes in Latin America, 2018 and 2019
Table 13.8: Latin America Urology Care Devices and Platforms Market, Impact Analysis
Table 13.9: Prevalence of Chronic Kidney Disease in Middle East and Africa, 2018 and 2019
Table 13.10: Middle East and Africa Urology Care Devices and Platforms Market, Impact Analysis
Figure 1: Global Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 2: Global Urology Care Devices and Platforms Market, Impact Analysis of Growth Promoting and Inhibiting Factors
Figure 3: Global Urology Care Devices and Platforms Market Share Analysis (by Company)
Figure 4: Global Urology Care Devices and Platforms Market (by End User), 2019 and 2030
Figure 5: Global Urology Care Devices and Platforms Market (by Region), 2019 and 2030
Figure 2.1: Global Urology Care Devices and Platforms Market Segmentation
Figure 3.1: Global Urology Care Devices and Platforms Market: Research Methodology
Figure 3.2: Primary Research
Figure 3.3: Secondary Research
Figure 3.4: Total Number of Healthcare Company Profiles
Figure 3.5: Assumptions and Limitations
Figure 4.1: Global Urology Care Devices and Platforms Market, Scenario Comparative Analysis
Figure 5.1: Global Prevalence, Kidney Diseases, 2000-2030
Figure 5.2: Global Prevalence, Urological Cancer, 2000-2030
Figure 5.3: Global Prevalence, Other Urological Diseases, 2000-2030
Figure 5.4: Global Urological Procedures Trend, 2010-2020
Figure 5.5: Global Transurethral Prostatectomy Procedure Volume, 2010-2020
Figure 5.6: Open Prostatectomy Procedure Volume, 2010-2020
Figure 5.7: Laparoscopic Hysterectomy Procedure Volume, 2010-2020
Figure 5.8: Hysterectomy Procedure Volume, 2010-2020
Figure 6.1: Global Urology Care Devices and Platforms Market: Key Technology Trends
Figure 6.2: Global Urology Care Devices and Platforms Market: Key Trends (Short-Term Potential)
Figure 6.3: Global Urology Care Devices and Platforms Market: Key Trends (Long-Term Potential)
Figure 6.4: Global Urology Care Devices and Platforms Market, Value Chain Analysis
Figure 6.5: Global Urology Care Devices and Platforms End-User Perceptions
Figure 6.6: FDA 510(k) Approval Timeline
Figure 6.7: Health Canada Class IV-Medical Device Approval Process
Figure 6.8: European Commission Class IV-Medical Device Approval Process
Figure 6.9: National Medical Products Administration Medical Device Approval Process
Figure 6.10: Pharmaceutical and Medical Devices Agency (PMDA) Medical Device Approval Process
Figure 6.11: Global Urology Care Devices and Platforms Market, Patent Filing Trend, January 2015-June 2021
Figure 6.12: Global Urology Care Devices and Platforms Market, Patent Filing Trend (by Country)
Figure 7.1: Global Urology Care Devices and Platforms Market Share Analysis (by Company), 2020
Figure 7.2: Global Urology Care Devices and Platforms Market Share Analysis (Conventional Devices (by Company)), 2020
Figure 7.3: Global Urology Care Devices and Platforms Market Share Analysis (Advanced Devices (by Company)), 2020
Figure 7.4: Global Urology Care Devices and Platforms Market Share Analysis (Platforms (by Company)), 2020
Figure 7.5: Share of Key Developments and Strategies in the Global Urology Care Devices and Platforms Market (by Category), January 2018-June 2021
Figure 7.6: Regulatory and Legal Activities (by Company), January 2018-June 2021
Figure 7.7: Partnerships and Alliances (by Company), January 2018-June 2021
Figure 7.8: New Offerings (by Company), January 2018-June 2021
Figure 7.9: Mergers and Acquisitions (by Company), January 2018-June 2021
Figure 7.10: Expansion Activities (by Company), January 2018-June 2021
Figure 8.1: Global Urology Care Devices and Platforms Market, Realistic Scenario, $Million, 2019-2030
Figure 8.2: Global Urology Care Devices and Platforms Market, Pessimistic/ Conservative Growth Scenario, $Million, 2019-2030
Figure 8.3: Global Urology Care Devices and Platforms Market, Optimistic Scenario, $Million, 2019-2030
Figure 8.4: Global Urology Care Devices and Platforms Market, Impact Analysis
Figure 8.5: Healthcare Records Compromised During June 2020-May 2021
Figure 8.6: Location of Breached Healthcare Data, May 2021
Figure 9.1: Global Urology Care Devices and Platforms Market Increment Opportunity (by Product), $Million, 2019 and 2030
Figure 9.2: Global Urology Care Devices and Platforms Market (Devices), $Million, 2019-2030
Figure 9.3: Global Urology Care Devices and Platforms Market (Conventional Devices), $Million, 2019-2030
Figure 9.4: Global Urology Care Devices and Platforms Market (Instruments), $Million, 2019-2030
Figure 9.5: Global Urology Care Devices and Platforms Market (Dialysis Devices), $Million, 2019-2030
Figure 9.6: Global Urology Care Devices and Platforms Market (Hemodialysis Devices), $Million, 2019-2030
Figure 9.7: Global Urology Care Devices and Platforms Market (Peritoneal Dialysis Devices), $Million, 2019-2030
Figure 9.8: Global Urology Care Devices and Platforms Market (Endoscopy and Imaging Devices), $Million, 2019-2030
Figure 9.9: Global Urology Care Devices and Platforms Market (Uteroscopes), $Million, 2019-2030
Figure 9.10: Global Urology Care Devices and Platforms Market (Nephroscopes), $Million, 2019-2030
Figure 9.11: Global Urology Care Devices and Platforms Market (by Cystoscopes), $Million, 2019-2030
Figure 9.12: Global Urology Care Devices and Platforms Market (Others), $Million, 2019-2030
Figure 9.13: Global Urology Care Devices and Platforms Market (Lasers and Lithotripsy Devices), $Million, 2019-2030
Figure 9.14: Global Urology Care Devices and Platforms Market (Endoscopy Fluid Management System), $Million, 2019-2030
Figure 9.15: Global Urology Care Devices and Platforms Market (Insufflators), $Million, 2019-2030
Figure 9.16: Global Urology Care Devices and Platforms Market (Urodynamic Systems), $Million, 2019-2030
Figure 9.17: Global Urology Care Devices and Platforms Market (Consumables and Accessories), $Million, 2019-2030
Figure 9.18: Global Urology Care Devices and Platforms Market (Guidewires and Catheters), $Million, 2019-2030
Figure 9.19: Global Urology Care Devices and Platforms Market (Ureteral Stents), $Million, 2019-2030
Figure 9.20: Global Urology Care Devices and Platforms Market (Biopsy Devices), $Million, 2019-2030
Figure 9.21: Global Urology Care Devices and Platforms Market (Others), $Million, 2019-2030
Figure 9.22: Global Urology Care Devices and Platforms Market (Advanced Devices), $Million, 2019-2030
Figure 9.23: Global Urology Care Devices and Platforms Market (Neurostimulator), $Million, 2019-2030
Figure 9.24: Global Urology Care Devices and Platforms Market (Robotic System), $Million, 2019-2030
Figure 9.25: Global Urology Care Devices and Platforms Market (Others), $Million, 2019-2030
Figure 9.26: Global Urology Care Devices and Platforms Market (by Platforms), $Million, 2019-2030
Figure 10.1: Global Urology Care Devices and Platforms Market Increment Opportunity (by Application), $Million, 2019 and 2030
Figure 10.2: Global Urology Care Devices and Platforms Market (Treatment), $Million, 2019-2030
Figure 10.3: Global Urology Care Devices and Platforms Market (Diagnosis and Monitoring), $Million, 2019-2030
Figure 11.1: Global Urology Care Devices and Platforms Market Increment Opportunity (by End User), $Million, 2019 and 2030
Figure 11.2: Global Urology Care Devices and Platforms Market (Hospitals, Ambulatory Surgery Centers, and Clinics), $Million, 2019-2030
Figure 11.3: Global Urology Care Devices and Platforms Market (Dialysis Centers), $Million, 2019-2030
Figure 11.4: Global Urology Care Devices and Platforms Market (Homecare Settings), $Million, 2019-2030
Figure 12.1: Global Urology Care Devices and Platforms Market Increment Opportunity (by Indication), $Million, 2019 and 2030
Figure 12.2: Global Urology Care Devices and Platforms Market (Kidney Diseases), $Million, 2019-2030
Figure 12.3: Global Urology Care Devices and Platforms Market (Urological Cancer and Benign Prostatic Hyperplasia), $Million, 2019-2030
Figure 12.4: Global Urology Care Devices and Platforms Market (Pelvic Organ Prolapse), $Million, 2019-2030
Figure 12.5: Global Urology Care Devices and Platforms Market (Other Diseases), $Million, 2019-2030
Figure 13.1: Global Urology Care Devices and Platforms Market (by Region), 2019 and 2030
Figure 13.2: North America Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.3: North America Urology Care Devices and Platforms Market (by Indication), $Million, 2019-2030
Figure 13.4: North America Urology Care Devices and Platforms Market (by End User), $Million, 2019-2030
Figure 13.5: North America Urology Care Devices and Platforms Market (by Country), $Million, 2019 and 2030
Figure 13.6: U.S. Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.7: Canada Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.8: Europe Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.9: Europe Urology Care Devices and Platforms Market (by Indication), $Million, 2019-2030
Figure 13.10: Europe Urology Care Devices and Platforms Market (by End User), $Million, 2019-2030
Figure 13.11: Europe Urology Care Devices and Platforms Market (by Country), $Million, 2019 and 2030
Figure 13.12: Germany Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.13: U.K. Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.14: France Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.15: Italy Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.16: Spain Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.17: Rest-of-Europe Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.18: Asia-Pacific Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.19: Asia-Pacific Urology Care Devices and Platforms Market (by Indication), $Million, 2019-2030
Figure 13.20: Asia-Pacific Urology Care Devices and Platforms Market (by End User), $Million, 2019-2030
Figure 13.21: Asia-Pacific Urology Care Devices and Platforms Market (by Country), $Million, 2019 and 2030
Figure 13.22: Japan Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.23: China Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.24: India Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.25: South Korea Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.26: Australia and New Zealand Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.27: Rest-of-Asia-Pacific Urology Care Devices and Platforms Market, $Million, 2018-2030
Figure 13.28: Latin America Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.29: Latin America Urology Care Devices and Platforms Market (by Indication), $Million, 2019-2030
Figure 13.30: Latin America Urology Care Devices and Platforms Market (by End User), $Million, 2019-2030
Figure 13.31: Latin America Urology Care Devices and Platforms Market (by Country), $Million, 2019 and 2030
Figure 13.32: Brazil Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.33: Mexico Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.34: Argentina Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.35: Rest-of-Latin America Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.36: Middle East and Africa Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.37: Middle East and Africa Urology Care Devices and Platforms Market (by Indication), $Million, 2019-2030
Figure 13.38: Middle East and Africa Urology Care Devices and Platforms Market (by End User), $Million, 2019-2030
Figure 13.39: Middle East and Africa Urology Care Devices and Platforms Market (by Country), $Million, 2019 and 2030
Figure 13.40: K.S.A. Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.41: Israel Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.42: South Africa Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 13.43: Rest-of-Middle East and Africa Urology Care Devices and Platforms Market, $Million, 2019-2030
Figure 14.1: Avenda Health: Product Portfolio
Figure 14.2: Avenda Health: SWOT Analysis
Figure 14.3: B. Braun Melsungen AG.: Product Portfolio
Figure 14.4: B. Braun Melsungen AG.: Overall Financials, 2018-2020
Figure 14.5: B. Braun Melsungen AG.: Revenue (by Business Segment), 2018-2020
Figure 14.6: B. Braun Melsungen AG.: Revenue (by Region), 2018-2020
Figure 14.7: B. Braun Melsungen AG: R&D Expenditure, 2018-2020
Figure 14.8: B. Braun Melsungen AG: SWOT Analysis
Figure 14.9: Becton, Dickinson and Company: Overall Product Portfolio
Figure 14.10: Becton, Dickinson and Company: Overall Financials, 2018-2020
Figure 14.11: Becton, Dickinson and Company: Revenue (by Business Segment), 2018-2020
Figure 14.12: Becton, Dickinson and Company: Revenue (by Region), 2018-2020
Figure 14.13: Becton, Dickinson, and Company: R&D Expenditure, 2018-2020
Figure 14.14: Becton, Dickinson and Company: SWOT Analysis
Figure 14.15: Boston Scientific Corporation: Overall Product Portfolio
Figure 14.16: Boston Scientific Corporation: Overall Financials, 2018-2020
Figure 14.17: Boston Scientific Corporation: Revenue (by Business Segment), 2018-2020
Figure 14.18: Boston Scientific Corporation: Revenue (by Region), 2018-2020
Figure 14.19: Boston Scientific Corporation: R&D Expenditure, 2018-2020
Figure 14.20: Boston Scientific Corporation: SWOT Analysis
Figure 14.21: Cardinal Health, Inc.: Overall Product Portfolio
Figure 14.22: Cardinal Health, Inc.: Overall Financials, 2018-2020
Figure 14.23: Cardinal Health, Inc.: Revenue (by Business Segment), 2018-2020
Figure 14.24: Cardinal Health, Inc.: Revenue (by Region), 2018-2020
Figure 14.25: Cardinal Health, Inc.: SWOT Analysis
Figure 14.26: Cook Group: Overall Product Portfolio
Figure 14.27: Cook Group: SWOT Analysis
Figure 14.28: Fresenius Medical Care AG & Co. KGaA: Overall Product Portfolio
Figure 14.29: Fresenius Medical Care AG & Co. KGaA: Overall Financials, 2018-2020
Figure 14.30: Fresenius Medical Care AG & Co. KGaA: Revenue (by Segment), 2018-2020
Figure 14.31: Fresenius Medical Care AG & Co. KGaA: Revenue (by Region), 2018-2020
Figure 14.32: Fresenius Medical Care AG & Co. KGaA: R&D Expenditure, 2018-2020
Figure 14.33: Fresenius Medical Care AG & Co. KGaA: SWOT Analysis
Figure 14.34: Intuitive Surgical, Inc.: Overall Product Portfolio
Figure 14.35: Intuitive Surgical, Inc.: Overall Financials, 2018-2020
Figure 14.36: Intuitive Surgical, Inc.: Revenue (by Segment), 2018-2020
Figure 14.37 Intuitive Surgical, Inc.: Revenue (by Region), 2018-2020
Figure 14.38: Intuitive Surgical Inc.: SWOT Analysis
Figure 14.39: Karl Storz SE & Co. KG: Overall Product Portfolio
Figure 14.40: Karl Storz SE & Co. KG: SWOT Analysis
Figure 14.41: Lucida Medical Ltd: Product Portfolio
Figure 14.42: Lucida Medical Ltd: SWOT Analysis
Figure 14.43: Medtronic plc: Overall Product Portfolio
Figure 14.44: Medtronic plc: Overall Financials, 2018-2020
Figure 14.45: Medtronic plc: Revenue (by Segment), 2018-2020
Figure 14.46: Medtronic plc: Revenue (by Region), 2018-2020
Figure 14.47: Medtronic plc: R&D Expenditure, 2018-2020
Figure 14.48: Medtronic plc: SWOT Analysis
Figure 14.49: Px Healthcare Ltd.: Product Portfolio
Figure 14.50: Px Healthcare Ltd.: SWOT Analysis
Figure 14.51: Richard Wolf GmbH: Product Portfolio
Figure 14.52: Richard Wolf GmbH: SWOT Analysis
Figure 14.53: Rocamed: Product Portfolio
Figure 14.54: Rocamed: SWOT Analysis
Figure 14.55: Urologix, LLC.: Product Portfolio
Figure 14.56: Urologix, LLC.: SWOT Analysis
Market Report Coverage
|
Urology Care Devices and Platforms Market |
|||
|
Base Year |
2019 |
Market Size in 2019 |
$13.61 Billion |
|
Forecast Period |
2021-2030 |
Value Projection and Estimation by 2030 |
$33.64 Billion |
|
CAGR During Forecast Period |
9.04% |
Number of Tables |
19 |
|
Number of Pages |
293 |
Number of Figures |
185 |
|
Market Segmentation |
• Product- Devices (Conventional Devices and Advanced Devices) and Platforms • Application- Treatment and Diagnosis and Monitoring • Indication- Kidney Diseases, Urological Cancer and Benign Prostatic Hyperlapsia, Pelvic Organ Prolapse, and Other Diseases • End User- Hospitals, Ambulatory Surgery Centers, and Clinics, Dialysis Centers, and Home Care Settings |
||
|
Regional Segmentation |
• North America – U.S., Canada • Europe – Germany, U.K, France, Italy, Spain, and Rest-of-Europe • Asia-Pacific – Japan, China, India, South Korea, Australia and New Zealand, and Rest-of-Asia-Pacific • Latin America – Brazil, Mexico, Argentina, and Rest-of-Latin-America • Middle East and Africa – K.S.A., Israel, South Africa, and Rest-of-Middle East and Africa |
||
|
Market Growth Drivers |
• Rising Prevalence of Urological Disorders • Rising Technology Integration • Product Portfolio Expansion through Mergers and Acquisitions |
||
|
Market Challenges |
• High Upfront Cost of Devices • Data Privacy Concerns |
||
|
Market Opportunities |
• Adoption of Telesurgery in Urological Practices • Emergence of Regional Companies • Development of Remote Patient Monitoring Devices |
||
|
Key Companies Profiled |
Avenda Health, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., Cook Group, Fresenius Medical Care AG & Co. KGaA, Intuitive Surgical, Inc., KARL STORZ SE & Co KG, Lucida Medical Ltd, Medtronic plc, Px HealthCare Ltd., Richard Wolf GmbH, Rocamed, Urologix, LLC. |
||
How This Report Can Add Value
Who should buy this report?
• Technology/non-healthcare companies planning to enter the urology market through a platform, mobile application, or smart device
• Urological device manufacturers
• AI-enabled platform developers
• Imaging modalities companies (specifically for urology)
• Endoscope manufacturers
Key questions answered in the Global Urology Care Devices and Platforms Market Report
• How has COVID-19 impacted the adoption of urology care devices and platforms applications?
• What are the key regulations governing the urology care devices and platforms market in key regions?
• What are the technological developments projected to have the maximum influence on the global urology care devices and platforms market?
• Who are the leading players holding significant dominance in the global urology care devices and platforms market currently?
• What are the drivers and restraints for the global urology care devices and platforms market?
• Which region has the highest growth rate in the urology care devices and platform market?
• Who are the key end-users of the global urology care devices and platform market?
• Which are the emerging companies in the global urology care devices and platforms market?
Report Summary
Global Urology Care Devices and Platforms Market Overview
The scope of the global urology care devices and platforms market involves conventional and advanced devices as well as platforms that are used in urological disease management. The conventional devices include dialysis devices, endoscopy and urology-specific imaging devices, lasers and lithotripsy devices, endoscopy fluid management systems, insufflators, and urodynamic systems. Furthermore, consumables such as guidewires and catheters, stents, biopsy devices, and other disposable consumables such as drainage bags, sheaths, and stone retrieval baskets are also categorized as conventional devices. The advanced devices include technology-enabled devices such as neurostimulators, robotic systems, and other emerging technology devices used for urology disorder management.
The global urology care devices and platforms market comprises of various key medical device companies and emerging companies. The major medical device companies operating in the market include Baxter International Inc., Olympus Corporation, Boston Scientific Corporation, Becton, Dickinson and Company, and Medtronic plc.
However, owing to the rising technology penetration and demand for minimally invasive procedures, various novel companies such as Axonics Modulation Technologies, Inc., Micron Medical Corporation, and robotic system companies such as Intuitive Surgical, Inc. have also entered the market and are offering advanced devices such as neurostimulators for urological treatment. Additionally, owing to the rising demand for remote patient monitoring and integration of digital solutions, emerging companies such as CareLogiQ Corp, Renalytix AI plc, and Healthy.io Ltd have entered the market and are projected to witness significant growth during the forecast period 2021-2030.
The pipeline of global urology care devices and platforms market primarily comprises advanced devices and platforms. Various companies such as Implantica AG, Micron Medical, Lucida Medical, and Neuspera Medical have products in the pipeline that are anticipated to be commercialized by the end of 2030. The launch of these products is projected to propel technology integration in the urology care landscape.
The factors driving growth include rising prevalence of urological disorders, rising technology integration, and product portfolio expansion through mergers and acquisitions. The restraints to the global urology care devices and platforms market include high upfront cost of the devices and data privacy concerns. The opportunities for the global urology care devices and platforms market lie in the adoption of telesurgery in urological practices, emergence of regional companies, and development of remote patient monitoring devices.
Key technology trends such as the switch from open procedures to minimally invasive procedures, inclusion of telemedicine in urology practices, remote patient monitoring devices, and integration of artificial intelligence (AI) for improved patient assessment are anticipated to influence the global urology care devices and platforms market. AI has been integrated into various healthcare applications for improved data analytics. AI inclusion in diagnosis, medical imaging, data collection, result interpretation, and treatment planning has improved physician's decision-making quality.
The global urology care devices and platforms market has witnessed significant technology integration in the past few years. There has been significant design- and product-level innovations in the market. For instance, more than 5,100 patents have been filed from January 2015 -June 2021, with the highest number of filings in 2019 (1,792 patents).
During January 2018-June 2021, the global urology care devices and platforms market witnessed 50 key developments. Regulatory and legal activities were the most actively employed strategies, followed by mergers and acquisitions. The key companies that received regulatory approvals between January 2018-June 2021 included Advanced MedTech Holdings Pte. Ltd., Baxter International Inc., Medtronic plc, Teleflex Incorporated, Axonics Modulation Technologies, Aveda Health, and Lucida Medical Ltd. Similarly, several partnerships took place between January 2018-June 2021. The aim of strategic partnerships includes new product development, strengthening of distribution network, and business expansion.
New product launches are one of the primary strategies adopted by new companies to enter in the global urology care devices and platforms market. Companies have also been working on upgrades for their existing products. Between January 2018-June 2021, several new products were launched in the global urology care devices and platforms market. Companies such as Advanced MedTech Holdings Pte. Ltd., B. Braun Melsungen AG, Teleflex Incorporated, and Stryker Corporation launched their products in the mentioned period. Furthermore, funding activities are critical for the entry and operation of start-ups in the global urology care devices and platforms market. Advanced MedTech Holdings is one of the prominent investors in the global urology care devices and platforms market that has regularly invested in various start-ups.
Two business models, namely, business to customer (B2C) and distributor network, are operational in the global urology care devices and platforms market. The device manufacturers often employ both the business models for ensuring a prominent local and global presence. Furthermore, owing to the emergence of platforms companies enabling remote patient monitoring and improved imaging analytics, software-as-a-service (SaaS) is anticipated to become one of the prominent business models in the market.
The global urology care devices and platforms market report highlights that the market was valued at $13.61 billion in 2019 and is expected to reach $33.64 billion by the end of 2030. The market is expected to grow at a CAGR of 9.04% during the forecast period from 2021 to 2030.
Global Urology Care Devices and Platforms Market Drivers
The factors driving growth include rising prevalence of urological disorders, rising technology integration, and product portfolio expansion through mergers and acquisitions. The high susceptibility of diabetic patients to urinary tract infections (UTI) is a major factor for growing urological disorder cases. Thus, with the rise in diabetic patients across the world, UTIs are becoming widespread.
There has been a shift in preference by urologists toward single use endoscopes as compared to reusables. This is due to the risk of contamination associated with reusable endoscopes. Additionally, the usage of minimally invasive procedures as treatment for lower urinary tract symptoms (LUTS) has drastically increased since 2013.
Lastly, there have also been several key mergers and acquisitions in the field of urology that have driven the global urology care devices and platforms market. This assists the companies in gaining access to newer technologies and strengthening their product offering.
Global Urology Care Devices and Platforms Market Challenges
The restraints to the global urology care devices and platforms market include high upfront cost of the devices and data privacy concerns.
While singe use instruments such as endoscopes have benefits that outweigh those of reusable devices, a major limitation encountered with single use instruments is their high upfront cost which puts pressure on the global urology care devices and platforms market. This causes an increase in hospital expenditure which subsequently leads to higher treatment costs. As a result, healthcare becomes both less affordable and accessible.
Data breaches are a huge source of concern for healthcare organizations as such incidents can cause legal issues and increase the risk of the practice being shut down. Such cases negatively influence the global urology care devices and platforms market and thus, pose a hindrance to the growth of the market.
Global Urology Care Devices and Platforms Market Opportunities
The opportunities for the global urology care devices and platforms market lie in the adoption of telesurgery in urological practices, emergence of regional companies, and development of remote patient monitoring devices.
Under the realm of telemedicine, telesurgery is one of the most challenging yet promising areas. Technological advancement and the development of high-speed internet with a wide bandwidth have positively influenced the field of telesurgery and telesurgical monitoring. While telesurgery holds potential in the field of global urology care devices and platforms market, it is advancement in telecommunication technologies that will allow telesurgery’s applications in the field of education as well as assistance in urological procedures.
With more companies venturing into developing products with novel technologies, there is increased competition among the players in the global urology care devices and platforms market. While the major players in the global urology care devices and platforms market hold a larger market share, newer start-ups are focusing on entering the market by launching products that integrate concepts like artificial intelligence AI and machine learning (ML) into their devices. This gives them an edge over the already existing products.
There are a number of remote patient monitoring devices in the global urology care devices and platforms market currently, such as CarePath by I-O Urology, CarelogiQ by CareLogiQ Corp, and KidneyIntelX by Renalytix AI plc, s. The demand for the devices is projected to grow in the future owing to the growing preference among patients and physicians, continuous patient monitoring, improvement in the decision-making process, and accelerated prognosis and treatment planning.
Impact of COVID-19 on Global Urology Care Devices and Platforms Market
In the short term, i.e., 2-4 years from 2020, COVID-19 would have a high impact on the global urology care devices and platforms market. The demand for remote patient monitoring devices is anticipated to be highest during this timeframe.
5-10 years from 2020, the resumption of elective surgeries and normalization of the supply chain would be the key factors for market recovery. Finally, in the long term, i.e., 8-12 years from 2020, the supply chain, production, and installation of conventional and advanced urology care devices are anticipated to be normalized.
Market Segmentation
Global Urology Care Devices and Platforms Market (by Product)
The global urology care devices and platforms market (by product) is segmented into conventional and advanced devices as well as platforms. The conventional devices include dialysis devices, endoscopy and urology-specific imaging devices, lasers and lithotripsy devices, endoscopy fluid management systems, insufflators, and urodynamic systems. Furthermore, consumables such as guidewires and catheters, stents, biopsy devices, and other disposable consumables such as drainage bags, sheaths, and stone retrieval baskets are also categorized as conventional devices. The advanced devices include technology enabled devices such as neurostimulators, robotic systems, and other emerging technology devices used for urology disorder management.
Global Urology Care Devices and Platforms Market (by Application)
The global urology care devices and platforms market (by application) is segmented into treatment, and diagnostics and monitoring. In terms of opportunities, the global urology care devices and platforms market holds significant growth potential for the diagnosis and monitoring segment. The shifting preference from at-clinic to at-home diagnostic and monitoring services presents abundant opportunities for the segment.
Global Urology Care Devices and Platforms Market (by End User)
The global urology care devices and platforms market (by end user) is segmented into hospitals, ambulatory surgery centers (ASCs), and clinics, dialysis centers, and home care settings. In terms of end user, the global urology care devices and platforms market holds significant growth opportunities in ASCs and homecare settings segment. This is owing to the growing prevalence of urological conditions, rise in adoption of remote patient monitoring devices, and rising demand for homecare. However, the predominance of hospitals and clinics is anticipated to continue during the forecast period 2021- 2030.
Global Urology Care Devices and Platforms Market (by Indication)
The global urology care devices and platforms market (by indication) is segmented into kidney diseases, urological cancer and benign prostatic hyperplasia, pelvic organ prolapse, and other diseases. The global urology care devices and platforms market holds significant potential in urological disorders such as kidney diseases, benign prostatic hyperplasia (BPH), bladder cancer, prostate cancer, and urinary incontinence. The rising prevalence of kidney diseases is attributed to factors such as a sedentary lifestyle, an unhealthy diet, and genetics. There are several conventional as well as advanced devices and platforms indicated to diagnose, treat, and monitor these urological disorders.
Global Urology Care Devices and Platforms Market (by Region)
The different regions covered under the global urology care devices and platforms market report include North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
North America dominated the global urology care devices and platforms market in 2019 and is anticipated to uphold its dominance throughout the forecast period. The growth in the market is majorly driven by the increasing research and development activities and large-scale adoption of global urology care devices and platforms. Also, the ongoing trend for digital transformation through the development of platforms and mobile applications is putting a significant impact on the market growth.
Key Market Players and Competition Synopsis
Avenda Health, B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Cardinal Health, Inc., Cook Group, Fresenius Medical Care AG & Co. KGaA, Intuitive Surgical, Inc., KARL STORZ SE & Co KG, Lucida Medical Ltd, Medtronic plc, Px HealthCare Ltd., Richard Wolf GmbH, Rocamed, and Urologix, LLC.
The global urology care devices and platforms market has witnessed several strategic and technological developments in the past few years, undertaken by the different market players to attain their respective market shares in this emerging domain. Some of the strategies covered in this segment are regulatory and legal activities, partnerships and alliances, new offerings, mergers and acquisitions, expansion activities, and funding activities.
Global Urology Care Devices and Platforms Market
Focus on Product Type, Application, Indication, End User, and Regional Analysis
Some Faq's
Frequently Asked Questions
The global urology care devices and platforms market is expected to grow at a CAGR of 9.04% during the forecast period from 2021-2030.
Factors driving the growth of the market include rising prevalence of urological disorders, rising technology integration in urology care, and product portfolio expansion through mergers and acquisitions.
High upfront cost of devices and data privacy concerns are the major factors restricting the growth of the market.
Urology care devices can be used for indications such as kidney diseases, urological cancer and benign prostatic hyperlapsia, pelvic organ prolapse, and other diseases.
Key companies operating in the market include Intuitive Surgical, Inc., KARL STORZ SE & Co KG, Lucida Medical Ltd, Medtronic plc, Px HealthCare Ltd., Richard Wolf GmbH, Rocamed, Urologix, LLC., among others.
Similar Product
You may also like
Published Year: 2021
Global Surgical Robotics Market: Focus on Vendor Analysis, Key Enabling Technologies, Emerging Platf
The market for surgical robotics generated $5.46 billion in 2020, in terms of value and is...
Published Year: 2020
Global Single-Use/Disposable Endoscopy Market: Analysis and Forecast, 2021-2030
The global single-use/disposable endoscopy market was estimated to be $471.7 million in...